Ask us a question
Trading
INDUSTRY
STATUS
OPEN TO
QBiotics research and development program is based on compounds derived from the Australian tropical rainforest.
The product focus addresses unmet medical needs for humans and companion animals, with a concentration on the global health priority areas of cancer, specifically solid tumours, and chronic wound management.
QBiotics is an Australian life sciences company, inspired by nature to improve human and animal health.
Pursuing both monotherapy and combination therapy avenues in clinical trials to test efficacy and safety – results of these studies provided a clinically relevant and highly validated model for cancer in humans
Current Market Cap >A$500M
850,000 shares available
Dr Peter Schmidt
Chief Operating Officer
Michael Wenzel
Chief Financial Officer
Mary Phipps
Chief Marketing Officer
Dr Richard Yocum
Chief Medical Officer
Roberta Bozzili
Chief Legal & Commercial Officer
Ebru Davidson
General Counsel
Dr Tracey Mynott
Business Development Manager
Dr Sam Yurdakul
Director of Prduct Development